Goldman Sachs Call 240 PGR 16.08..../ DE000GG51VJ9 /
2024-05-06 9:59:21 AM | Chg.-0.040 | Bid10:00:39 PM | Ask10:00:39 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.260EUR | -13.33% | - Bid Size: - |
- Ask Size: - |
Progressive Corporat... | 240.00 USD | 2024-08-16 | Call |
GlobeNewswire
05-06
ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024
GlobeNewswire
05-06
IRSA: Promote the continuous development of China-France comprehensive strategic partnership
GlobeNewswire
05-06
4 Gen Logistics Advances Sustainable Goods Movement with 41 Volvo VNR Electric Trucks
GlobeNewswire
05-06
Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...
GlobeNewswire
05-04
The National Fire Sprinkler Association's Class of 2024: Honoring Fire Sprinkler Industry Greats
GlobeNewswire
05-02
PyroGenesis Announces 28-Day Lab Strength Tests Achieve Up to 99.56% Above Compressive Strength Targ...
GlobeNewswire
05-01
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...
GlobeNewswire
05-01
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 ...
GlobeNewswire
05-01
Atsena Therapeutics Announces Positive Clinical Data from the First Cohort of Phase I/II Trial Evalu...
GlobeNewswire
05-01
TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
04-25
Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Re...
GlobeNewswire
04-24
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society...
GlobeNewswire
04-22
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Snap One Ho...
GlobeNewswire
04-22
Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients i...
GlobeNewswire
04-19
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Scleros...